At-Home Drug of Abuse (DOA) Testing Market Size
Study Period | 2019 - 2029 |
Market Size (2024) | USD 719.78 Million |
Market Size (2029) | USD 933.61 Million |
CAGR (2024 - 2029) | 5.34 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
At-Home Drug of Abuse (DOA) Testing Market Analysis
The Global At-Home Drug of Abuse Testing Market size is estimated at USD 719.78 million in 2024, and is expected to reach USD 933.61 million by 2029, growing at a CAGR of 5.34% during the forecast period (2024-2029).
The studied market was impacted by the pandemic. With the advent of the pandemic, owing to the restrictions imparted by several governments on the travel and supply chain, the usual patterns of drug abuse were impacted throughout the world. The temporary bans affected the shipping of illicit drugs across the world, which widely impacted the market. According to the World Drug Report 2022, during the COVID-19 pandemic, there was an overall increase in the consumption of alcohol, tobacco, and cannabis, especially in the initial stages of the lockdowns. There was an increase in the consumption volumes owing to an increase in the frequencies and quantities of cannabis use, with herbal cannabis occupying a major portion.
The same source indicated that there was an increase in the non-medical use of sedatives, such as benzodiazepines, tranquilizers, and other psychiatric pharmaceuticals. However, there was a reduction in drug use among adolescents due to the lack of availability due to travel restrictions and social distancing, and close parental monitoring.
Also, owing to the reduction in the supply of illicit drugs, there was an increase in the local production of such drugs, which acted as an important factor adding to the market growth. For instance, according to an article titled 'Impact of COVID-19 Controls on the Use of Illicit Drugs and Alcohol in Australia' published in August 2021, there was a significant reduction in the availability of methamphetamine in Australia during the period of February to June 2020. Nonetheless, there was a considerable increase in the consumption of cannabis, along with other locally produced drugs. The use of such locally produced drugs is expected to boost the growth of the at-home drug abuse testing market. Thus, the market was adversely impacted by the pandemic however, it is expected to grow in the future.
Illicit drugs refer to substances that are illegal and highly addictive and can either stimulate or inhibit the central nervous system. The rise in the use and production of illicit drugs is expected to play a vital role in the growth of the at-home drug of abuse (DOA) testing market. There has been an increase in the use of illicit drugs around the world. For instance, according to the World Drug Report 2022 published by the United Nations in June 2022, cannabis had the greatest number of users in the world with over 209 million users in the year 2020. Opioids came second with over 61 million users consuming opioids for non-medical reasons. In the year 2020, 34 million people had used amphetamines, an estimated 20 million people used ecstasy, and around 21 million people used cocaine-type substances. The report also indicated that there had been an overall increase in the use of the drugs during the year 2019-2020. This increase in the use of such drugs is expected to boost the growth of the at-home DOA testing market.
Moreover, the rise in the production of illicit drugs is also aiding market growth. For instance, according to an article by the White House on poppy cultivation and potential heroin production in Mexico, the Office of National Drug Control Policy (ONDCP) indicated that in the year 2021, there was an increase in poppy cultivation in Mexico by 23%, from 23,200 hectares in 2020 to 28,600 hectares in 2021. Also, the potential pure production of heroin increased by 22%, from 59 metric tons in 2020 to 72 metric tons in 2021. This increasing production is expected to significantly propel the growth of the at-home DOA testing market over the forecast period.
Various government organizations around the world have established measures to curb the incidences of drug abuse. The White House in its National Drug Control Strategy published in April 2022 focused on measures to reduce the number of overdose deaths in the nation in the short term and the reduction of drug abuse and its damaging consequences over the longer term. The article indicated that as per the 2020 National Survey on Drug Use and Health (NSDUH), around 20 million people living in the United States affected by drug overdose were not receiving addiction treatment services. The rising necessity of the treatment has pressured the government to formulate measures to help improve the conditions of people undergoing drug abuse, which is expected to add to the growth of the studied market over the forecast period. Thus, the abovementioned factors are expected to increase the market growth.
However, lack of awareness of these testing devices is a constraint to the market growth.
At-Home Drug of Abuse (DOA) Testing Market Trends
This section covers the major market trends shaping the At-Home Drug Of Abuse Testing Market according to our research experts:
Test Strip Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Factors such as increasing drug overdose, research studies to understand the benefits of at-home drug test strips coupled with initiatives such as product launches by key market players are expected to increase the market growth.
Increasing drug overdose is one of the key factors to increasing the adoption of at-home drug testing strips. For instance, in February 2022, an article published by the Centers for Disease Control and Prevention titled "Provisional Drug Overdose Death Counts" stated that the Covid-19 pandemic has resulted in an increased risk of using drugs alone, changes to the drug supply, and initiation or increased use of substances by individuals. Thus, increasing drug-induced overdose is expected to increase the adoption of testing strips thus increasing the market growth.
In August 2022, a research study titled "Take-Home Drug Checking as a Novel Harm Reduction Strategy in British Columbia, Canada" was conducted by Vancouver Coastal Health (VCH), the BC Centre on Substance Use (BCCSU), the BC Centre for Disease Control (BCCDC), Interior Health (IH), and the First Nations Health Authority (FNHA), which was published in the International Journal of Drug Policy. The study proved how useful it is to provide fentanyl test strips for take-home use. Using take-home test strips and staff testing at harm reduction centres, researchers compared the rates of fentanyl detection. The take-home fentanyl test strips had positivity rates of 90% compared to 89.1% among 1,768 opioid drug samples examined. These rates were comparable to those achieved by trained staff at harm reduction centres.
Similarly, in April 2022, an article published titled "At-home test strips can detect fentanyl-but that's just the first step to preventing overdoses" stated that Alabama, Tennessee, and New Mexico all decriminalized the sale of test strips. Thus, increasing decriminalization of testing strips is another factor in market growth. Thus, the abovementioned factors are expected to increase segment growth.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. The dominant position of the market in this region is mainly due to the high number of people who are suffering from substance abuse and initiatives by the government. The rise in the use of illicit drugs in the region is likely to support the growth of the market. For instance, according to the updates in September 2022 by the Center for Diseases Control and Prevention, 13.0% of those aged 12 and up reported using illicit drugs in 2019. 1.9% of those aged 12 and up used a psychotherapeutic substance for nonmedical purposes in 2019. Thus, increasing the use of illicit drugs in the country and the demand for at-home drug abuse testing, thereby boosting the market growth.
Moreover, various initiatives are taken by the government to reduce drug abuse throughout support the market expansion through the forecast period. For instance, in September 2021, United Nations on Drugs and Crime reduce the drug can youngsters. Every year UNODC can promote drug use created and youth.
Similarly, in July 2021, the Canadian government announced the start of the national call for proposals (CFP) for Health Canada's Substance Use and Addictions Program for 2021. (SUAP). As part of the USD 116 million investment in Budget 2021, Health Canada is continuing to build successful community-based programs that can help prevent, treat, and/or reduce the harms associated with opioids, stimulants, alcohol, prescription drugs, and other substances that have a high risk of problematic use through this call for proposals. Such initiatives create awareness among the support about drug abuse which is likely to support the growth of the market. Thus, the aforementioned factors are expected to increase the market growth.
At-Home Drug of Abuse (DOA) Testing Industry Overview
The At-Home Drug of Abuse (DOA) Testing Market is moderately competitive with several major players. Some of the major players are Abbott Laboratories, Dragerwerk AG & Co. KGaA, Assure Tech.(Hangzhou) Co., LTD, Atlas Medical GmbH, and Confirm BioSciences among others.
At-Home Drug of Abuse (DOA) Testing Market Leaders
-
Abbott
-
Dragerwerk AG & Co. KGaA
-
Assure Tech.(Hangzhou) Co., LTD
-
Atlas Medical GmbH
-
Confirm BioSciences
*Disclaimer: Major Players sorted in no particular order
At-Home Drug of Abuse (DOA) Testing Market News
- In March 2022, the Department of Health and Human Services (HHS) offered funding of USD 58.5 million in contingency management tests for people with stimulant use disorder in California.
- In October 2021, the manufacturer of narcotics and explosives testing kits used by law enforcement and government organizations, VeritequeUSA Inc., introduced Verifique as its first consumer brand.
At-Home Drug of Abuse (DOA) Testing Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Use and Production of Illicit Drugs
4.2.2 Increasing Initiatives by Governemnt Organizations to Reduce Drug Abuse
4.3 Market Restraints
4.3.1 Lack of Awareness and Consideration of Drug Testing
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type
5.1.1 Test Cups
5.1.2 Test Strips
5.1.3 Others
5.2 By Sample Type
5.2.1 Saliva
5.2.2 Urine
5.2.3 Blood
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Dragerwerk AG & Co. KGaA
6.1.3 UCP Biosciences Inc.
6.1.4 Orient New Life Medical Co. Ltd.
6.1.5 Assure Tech. (Hangzhou) Co., LTD
6.1.6 Psychemedics Corporation
6.1.7 Confirm BioSciences
6.1.8 Phamatech Inc.
6.1.9 Atlas Medical GmbH
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
At-Home Drug of Abuse (DOA) Testing Industry Segmentation
As per the scope of the report, at-home drug of abuse (DOA) testing is a rapid test kit that can be used at home and present their results swiftly, in an easy method that anybody can understand them. The at-home drug of abuse (DOA) testing market is segmented by type (test cups, test strips, and others), sample type (saliva, urine, blood, and others), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the values (USD million) for the above segments.
By Type | |
Test Cups | |
Test Strips | |
Others |
By Sample Type | |
Saliva | |
Urine | |
Blood | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
At-Home Drug of Abuse (DOA) Testing Market Research FAQs
How big is the Global At-Home Drug of Abuse (DOA) Testing Market?
The Global At-Home Drug of Abuse (DOA) Testing Market size is expected to reach USD 719.78 million in 2024 and grow at a CAGR of 5.34% to reach USD 933.61 million by 2029.
What is the current Global At-Home Drug of Abuse (DOA) Testing Market size?
In 2024, the Global At-Home Drug of Abuse (DOA) Testing Market size is expected to reach USD 719.78 million.
Who are the key players in Global At-Home Drug of Abuse (DOA) Testing Market?
Abbott, Dragerwerk AG & Co. KGaA, Assure Tech.(Hangzhou) Co., LTD, Atlas Medical GmbH and Confirm BioSciences are the major companies operating in the Global At-Home Drug of Abuse (DOA) Testing Market.
Which is the fastest growing region in Global At-Home Drug of Abuse (DOA) Testing Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global At-Home Drug of Abuse (DOA) Testing Market?
In 2024, the North America accounts for the largest market share in Global At-Home Drug of Abuse (DOA) Testing Market.
What years does this Global At-Home Drug of Abuse (DOA) Testing Market cover, and what was the market size in 2023?
In 2023, the Global At-Home Drug of Abuse (DOA) Testing Market size was estimated at USD 683.29 million. The report covers the Global At-Home Drug of Abuse (DOA) Testing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global At-Home Drug of Abuse (DOA) Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
At-Home DOA Test Industry Report
Statistics for the 2024 At-Home DOA Test market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. At-Home DOA Test analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.